US Stock MarketDetailed Quotes
NWBO Northwest Biotherapeutics
- 0.460000
- -0.005940-1.27%
15min DelayClose May 3 16:00 ET
549.86MMarket Cap-7666P/E (TTM)
0.480000High0.458000Low1.27MVolume0.465000Open0.465940Pre Close594.72KTurnover0.12%Turnover RatioLossP/E (Static)1.20BShares1.09000052wk High-8.36P/B498.86MFloat Cap0.40010052wk Low--Dividend TTM1.08BShs Float112.000000Historical High--Div YieldTTM4.72%Amplitude0.140000Historical Low0.466000Avg Price1Lot Size
About Northwest Biotherapeutics Company
Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
Company Profile
SymbolNWBO
Company NameNorthwest Biotherapeutics
Issue Price5.00
Founded1996
MarketPink Market
Employees22
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4800 Montgomery Lane,Suite 800
CityBethesda
ProvinceMaryland
CountryUnited States of America
Zip Code20814
Phone1-240-497-9024
Websitehttp://www.nwbio.com
Company Executives
- Name
- Position
- Salary
- Linda F. Powers
- Chairman of the Board, President, Chief Financial and Accounting Officer and Chief Executive Officer
- --
- Alton L. Boynton
- Director and Chief Scientific Officer
- --
- Dr. Marnix L. Bosch
- Chief Technical Officer
- --
- Leslie J. Goldman
- Senior Vice President and General Counsel
- --
- Jerry Jasinowski
- Director
- --
- J. Cofer Black
- Director
- --
- Dr. Navid Malik
- Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg